Diagnostics and treatment strategies of depressive disorders in alcohol- dependent patients;Diagnostik und behandlungsansatze depressiver storungen bei alkoholabhangigen

Fortschritte der Neurologie Psychiatrie

Volumn 67, Issue 3, 1999, Pages 131-141

  Wetterling, Tilman ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYLCHOLINE; AMITRIPTYLINE; BACLOFEN; BETA ENDORPHIN; BUSPIRONE; CITALOPRAM; DESIPRAMINE; DOPAMINE; FLUOXETINE; GLUTAMIC ACID; IMIPRAMINE; LITHIUM; MIRTAZAPINE; NORADRENALIN; NORTRIPTYLINE; SEROTONIN; TIANEPTINE; VENLAFAXINE; VILOXAZINE; ANTIDEPRESSANT AGENT;

ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; COPING BEHAVIOR; DEPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; PREVALENCE; TREATMENT INDICATION; REVIEW;

ALCOHOLISM; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; HUMANS;

EID: 0032952608     PISSN: 07204299     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-993990     Document Type: Article

References (148)

1. Adinoff, B., P. R. Martin, G. H. Bone, M. J. Eckardt, L. Roehrich, D. T. George, H. B. Moss, R. Eskay, M. Linnoila, P. W. Gold: Hypothalamic-pituitary-adrenal axis functioning and cerebrospinal fluid corticotropin releasing hormone and corticotropin levels in alcoholics after recent and long-term abstinence. Arch. Gen. Psychiatry 4 (1990) 325-330
2. Allen, D., M. Lader, H. V. Curran: A comparative study of the interactions of alcohol with amitriptyline, fluoxetine and placebo in normal subjects. Prog. Neuropsychopharmacol. Biol. Psychiatry 12 (1988) 63-80
3. Alling, C., J. Balldin, K. Bökström, C. G Gottfries, I. Karlsson, G. Langstrom: Studies on duration of a late recovery period after chronic abuse of ethanol. A cross-sectional study of biochemical and psychiatric indicators. Acta Psychiatr. Scand. 66 (1982) 384-397
4. Altamura, A. C., M. C. Mauri, T. Girardi, B. Panetta: Alcoholism and depression: a placebo controlled study with viloxazine. Int. J. Clin. Pharmacol. Res. 10 (1990) 293-298
5. Angelone, S. M., L Bellini, D. Di Bella, M. Catalano: Effects of fluvoxamine and citalopram in maintaining abstinence in a sample of Italian detoxified alcoholics. Alcohol Alcohol. 33 (1998) 151-156
6. Anton, R. F., D. H. Moak, P. K. Latham: The obsessive compulsive drinking scale. Arch. Gen. Psychiatry 53 (1996) 217-226
7. Balldin, J., U. Berggren, J. Engel, M. Eriksson: Neuroendocrine evidence for reduced serotonergic neurotransmission during heavy drinking. Alcohol. Clin. Exp. Res. 18 (1994) 822-825
8. Balldin, J., U. Berggren, J. Engel, M. Eriksson, E. Hard, B. Soderpalm: Effect of citalopram on alcohol intake in heavy drinkers. Alcohol. Clin. Exp. Res. 18 (1994) 1133-1136
9. Ballenger, J. C., F. K. Goodwin, L. F. Major, G. L. Brown: Alcohol and central serotonin metabolism in man. Arch. Gen. Psychiatry 36 (1979) 224-227
10. Bandelow, H.: Therapie mit Antidepressiva. In: Fox, J. M., E. Rüther (Hrsg.): Handbuch der Arzneimitteltherapie. Band I: Psychopharmaka, Thieme, Stuttgart (1998) S. 67-118
11. Bandelow, H., E. Rüther: Serotonin und Depression. In: Beckmann, H., M. Osterheider (Hrsg.) Neurotransmitter und psychische Erkrankungen. Springer, Berlin (1990) S. 29-41
12. Baving, L., H. Olbrich: Angst bei Alkoholabhängigen. Fortschr. Neurol. Psychiat. 64 (1996) 83-89
13. Beck, A. T., C. H. Ward, M. Mendelson, J. Mock, J. Erbaugh: An Inventory for measuring depression. Arch. Gen. Psychiatry 4 (1961) 561-571
14. Behar, D., G. Winokur, C. J. Berg: Depression in the abstinent alcoholic. Am. J. Psychiatry 141 (1984) 1105-1107
15. Bökström, K., J. Balldin: A rating scale for assessment of alcohol withdrawal psychopathology (AWIP). Alcohol. Clin. Exp. Res. 16 (1992) 241-249
16. Booth, B. M., W. R. Yates, F. Petty, K. Brown: Patient factors predicting early alcohol-related readmissions for alcoholics: role of alcoholism severity and psychiatric co-morbidity. J. Stud. Alcohol 52 (1991) 37-43
17. Borg, S., H. Kvande, P. Liljeberg, D. Mossberg, P. Valverius: 5-Hydroxyindoleacetic acid in cerebrospinal fluid in alcoholic patients under different clinical conditions. Alcohol 2 (1985) 415-418
18. Bronisch, T.: Zur Beziehung zwischen Alkoholismus und Depression anhand eines Überblicks über empirische Studien. Fortschr. Neurol. Psychiat. 53 (1985) 454-468
19. Brown, S. A., M. A. Schuckit: Changes in depression among abstinent alcoholics. J. Stud. Alcohol 49 (1988) 412-417
20. Brown, S. A., R. K. Inaba, J. C. Gillin, M. A. Schuckit, M. A. Stewart, M. R. Irwin: Alcoholism and affective disorder: clinical course of depressive symptoms. Am. J. Psychiatry 152 (1995) 45-52
21. Bruno, F.: Buspirone in the treatment of alcoholic patients. Psychopathology 22 Suppl. 1 (1989) 49-59
22. Bucholz, K. K., R. Cadoret, C. R. Cloninger, S. H. Dinwiddie, V. M. Hesselbrock, J. I. Nurnberger, T. Reich, I. Schmidt, M. A. Schuckit: A new, semi-structured psychiatric interview for use in genetic linkage studies: a report on the reliability of the SSAGA. J. Stud. Alcohol 55 (1994) 149-158
23. Choquette, K. A.: Assessing depression in alcoholics with the BDI, SCL-90 R, and DIS criteria. J. Substance Abuse 6 (1994) 295-304
24. Choquette, K. A., M. N. Hesselbrock: Effects of retesting with the Beck and Zung depression in alcoholics. Alcohol Alcohol. 22 (1987) 277-283
25. Ciraulo, D. A., J. G. Barnhill, J. H. Jaffe: Clinical pharmacokinetics of imipramine and desipramine in alcoholics and normal volunteers. Clin. Pharmacol. Ther. 43 (1988) 509-518
26. Cornelius, J. R., I. M. Salloum, J. G. Ehler, P. J. Jarrett, M. D. Cornelius, J. M. Perel, M. E. Thase, A. Black: Fluoxetine in depressed alcoholics. A double-blind, placebo-controlled trial. Arch. Gen. Psychiatry 54 (1997) 700-705
27. Czarnecka, E., K. Kowalczyk, H. Kozbial: Interaction between central effects of ethanol and tricyclic antidepressants, imipramine and amitriptyline in mice and rats. Pol. J. Pharmacol. Pharmacy 41 (1989) 231-237
28. Dackis, C. A., M. S. Gold, A. L. C. Pottash, D. R. Sweeney. Evaluating depression in alcoholics. Psychiatrics Res. 17 (1986) 105-109
29. Davidson, K. M.: Diagnosis of depression in alcohol dependence: changes in prevalence with drinking status. Br. J. Psychiatry 166 (1995) 199-204
30. Degoratis, L. R., R. S. Lipman, L. Covi: SCL-90.An outpatient psychiatric rating scale-Preliminary report. Psychopharm. Bull 9 (1970) 13-28
31. Dildy-Mayfield, J. E., R. A. Harris: Neurobiology of alcohol actions and the addictive process. In: Tabakoff, B., P. L. Hoffmann (Hrsg.) Biological aspects of alcoholism. Hogrefe-Huber, Seattle (1995) S. 189-223
32. Dilling, H., W. Mombour, M. H. Schmidt: Internationale Klassifikation psychischer Störungen. ICD-10. 2. Aufl., Huber (1993)
33. Dorian, P., E. M. Sellers, K. L. Reed, J. J. Warsh, C. Hamilton, H. L. Kaplan, T. Fan: Amitriptyline and ethanol: pharmacokinetic and pharmacodynamic interaction. Eur. J. Clin. Pharmacol. 25 (1983) 325-331
34. Dorus, W., J. Kennedy, R. D. Gibbons, S. D. Ravi: Symptoms and diagnosis of depression in alcoholics. Alcohol. Clin. Exp. Res. 11 (1987) 150-154
35. Dorus, W., D. G. Ostrow, R. Anton, P. Cushman, J. F. Collins, M. Schaefer, H. I. Schaefer, H. L. Desai, M. Hayashida, U. Malkernekker, M. Willenbring, R. Fiscella, M. R. Sather: Lithium treatment of depressed and nondepressed alcoholics. JAMA 262 (1989) 1646-1652
36. Driessen, M., C. Veltrup, U. John, T. Wetterling, H. Dilling: Axis I and axis II comorbidity in alcohol dependence and the two types of alcoholism. Alcohol. Clin. Exp. Res. 22 (1998) 77-86
37. Driessen, M., C. Veltrup, J. Weber, U. John, T. Wetterling, H. Dilling: Psychiatric comorbidity, suicidal behaviour and suicidal ideation in alcoholics seeking treatment. Addiction 93 (1998) 889-894
38. Durcan, M. J., R. G. Lister, M. J. Eckardt, M. Linnoila: Interactions of 5 HT reuptake inhibitors and ethanol in tests of exploration and anxiety. Adv. Alcohol. Subst. Abuse 7 (1988) 113-117
39. Fawcett, J., D. C. Clark, A. C. Aagesen, V. D. Pisani, J. M. Tilkin, D. Sellers, M. McGuire, R. D. Gibbons: A double-blind, placebo-controlled trial of lithium carbonate therapy for alcoholism. Arch. Gen. Psychiatry 44 (1987) 248-256
40. Frewer, L. J., M. Lader: The effects of nefazodone, imipramine and placebo, alone and combined with alcohol, in normal subjects. Int. Clin. Psychopharmacol. 8 (1993) 13-20
41. Fils-Aime, M.-L., M. S. Eckhardt, D. T. George, G. L. Brown, I. Mefford, M. Linnoila: Early-onset alcoholics have lower cerebrospinal fluid 5-hydroxyindolacetic acid levels than late-onset alcoholics. Arch. Gen. Psychiatry 53 (1996) 211-216
42. Gammans, R. E., R. F. Mayol, J. A. LaBudde: Metabolism and disposition of buspirone. Am. J. Med. 80 Suppl. 3 B (1986) 41-51
43. George, D. T., D. J. Nutt, B. A. Dwyer, M. Linnoila: Alcoholism and panic disorders: is the comorbidity more than coincidence? Acta Psychiatr. Scand. 81 (1989) 97-107
44. Gillin, J. C., T. L. Smith, M. Irwin, D. F. Kripke, M. Schuckit: EEG sleep studies in "pure" primary alcoholism during subacute withdrawal: relationships to normal controls, age, and other clinical variables. Biol. Psychiatry 27 (1990) 477-488
45. Gillin, J. C., T. L. Smith, M. Irwin, N. Butters, A. Demodena, M. Schuckit: Increased pressure for rapid eye movement sleep at time of hospital admission predicts relapse in nondepressed patients with primary alcoholism at 3-month follow-up. Arch. Gen. Psychiatry 51 (1994) 189-197
46. Goldman, D. S., K. W. Bander: Six-month course of depression in female alcoholics. J. Subst. Abuse 2 (1990) 375-380
47. Gorelick, D. A., A. Paredes: Effect of fluoxetine on alcohol comsumption in male alcoholics. Alcohol. Clin. Exp. Res. 16 (1992) 261-265
48. Greenfield, S. F., R. D. Weiss, L. R. Muenz, L. M. Vagge, J. F. Kelly, L. R. Bello, J. Michael: The effect of depression on return to drinking: a prospective study. Arch. Gen. Psychiatry 55 (1998) 259-265
49. Greil, W., W. Ludwig-Mayerhofer, N. Erazo, C. Schöchlin, S. Schmidt, R. R. Engel, A. Czernik, H. Giedke, B. Muller-Oerlinghausen, M. Osterheider, G. A. Rudolf, H. Sauer, J. Tegeler, T. Wetterling: Lithium versus carbamazepine in the maintenance treatment of bipolar disorders-a randomised study. J. Affect. Dis. 43 (1997) 151-161
50. Hamilton, M.: A rating scale for Depression. J. Neurol. Neurosurg. Psychiatry 23 (1960) 56-62
51. Hasin, D. S., W. Y. Tsai, J. Endicott, T. I. Mueller, W. Coryell, M. Keller: Five-year course of major depression: effects of comorbid alcoholism. J. Affect. Disord. 41 (1996) 63-70
52. Heizer, J. E., T. R. Pryzbeck: The co-occurrence of alcoholism with other psychiatric disorders in the general population and its impact on treatment. J. Stud. Alcohol 49 (1988) 219-224
53. Hesselbrock, M. N., R. E. Meyer, J. J. Keener: Psychopathology in hospitalized alcoholics. Arch. Gen. Psychiatry 42 (1985) 1050-1055
54. Hesselbrock, V. M., M. N. Hesselbrock, K. L. Workman-Daniels: Effect of major depression and antisocial personality on alcoholism: course and motivational patterns. J. Stud. Alcohol May; 47 (3): (1986) 207-212
55. Hirschfeld, R. M., T. Rosier, M. B. Keller, P. W. Lavori, J. Endicott: The influence of alcoholism on the course of depression. J. Affect. Disord. 16 (1989) 151-158
56. Hüllinghorst, R.: Zur Versorgung Suchtkranker in Deutschland. DHS-Jahrbuch Sucht '95. Neuland, Geesthacht, (1995) S. 153-162
57. Janiri, L., G. Gobbi, P. Mannelli, G. Pozzi, A. Serretti, E. Tempesta: Effects of fluoxetine at antidepressant doses on short-term outcome of detoxified alcoholics. Int. Clin. Psychopharmacol. 11 (1996) 109-117
58. Jung, M.: Alkoholabhängigkeit und psychiatrische Komorbidität. In: Mann, K., G. Buchkremer(Hrsg.) Sucht. Grundlagen-Diagnostik-Therapie. Fischer, Stuttgart (1996), S. 157-168
59. Kabel, D. I., F. Petty: A placebo-controlled, double-blind study of fluoxetine in severe alcohol dependence: adjunctive pharmacotherapy during and after inpatient treatment. Alcohol. Clin. Exp. Res. 20 (1996) 780-784
60. Keeler, M. H., I. Taylor, M. C. Miller: Are all recently detoxified alcoholics depressed. Am. J. Psychiatry 136 (1979) 586-588
61. Kerr, J. S., J. Powell, I. Hindmarch: The effects of reboxetine and amitriptyline, with and without alcohol on cognitive function and psychomotor performance. Br. J. Clin. Pharmacol. 42 (1996) 239-241
62. Kessler, R. C., R. M. Crum, L. A. Warner, C. B. Nelson, J. Schulenberg, J. C. Anthony: Lifetime co-occurence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch. Gen. Psychiatry 54 (1997) 313-321
63. Kivlahan, D. R., D. M. Donovan, R. D. Walker: Predictors of relapse. Interaction of drinking-related locus of control and reasons for drinking. Addictive Behav. 8 (1983) 273-276
64. Kranzler, H. R., J. A. Burleson, F. K. Del Boca, T. F. Babor, P. Korner, J. Brown, M. J. Bohn: Buspirone treatment of anxious alcoholics. Arch. Gen. Psychiatry 51 (1994) 720-731
65. Kranzler, H. R., J. A. Burleson, P. Korner, F. K. Del Boca, M. J. Bohn, J. Brown, N. Liebowitz: Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention. Am. J. Psychiatry 151 (1995) 391-397
66. Krupitsky, E. M., A. M. Burakov, V. B. Ivanov, G. F. Krandashova, 1. P. Lapin, A. J. Grinenko, Y. S. Borodkin: Baclofen administration for the treatment of affective disorders in alcoholic patients. Drug Alcohol Dependence 33 (1993) 157-163
67. Lader, M., A. Melhuish, G. Frcka, K. F. Overo, V. Christensen: The effects of citalopram in single and repeated doses and with alcohol on physiological and psychological measures in healthy subjects. Eur. J. CHn. Pharmacol. 31 (1986) 183-190
68. Landauer, A. A., G. Milner, J. Patman: Alcohol and amitriptyline effects on skills related to driving behavior. Science 163 (1969) 1467-1468
69. Lemberger, L., H. Rowe, R. F. Bergstrom, K. Z. Farid, G. G. Enas: Effect of fluoxetine on psychomotor performance, physiologic response, and kinetics of ethanol. Clin. Pharmacol. Ther. 37 (1985) 658-664
70. Linnoila, M., J. Johnson, T. Dubyoski, R. Ross, M. Buchsbaum, W. Z. Potter, H. Weingartner: Effects of amitriptyline, desipramine and zimeldine, alone and in combination with ethanol, on information processing and memory in healthy volunteers. Acta Psychiatr. Scand. Suppl. 308 (1983) 175-181
71. Linnoila, M., I. Mefford, D. Nutt, B. Adinoff: Alcohol withdrawal and noradrenergic function. Ann. Int. Med. 107 (1987) 875-889
72. Lippmann, S., M. Manshadi, S. Christie, A. Gultekin: Depression in alcoholics by the NIMH-Diagnostic Interview Schedule and Zung Self-Rating Depression Scale. Int. J. Addict. 22 (1987) 273-281
73. Loo, H., R. Malka, R. Defrance, D. Barrucand, J. Y. Benard, H. Niox-Riviere, A. Raab, A. Sarda, G. Vachonfrance, A. Kamoun: Tianeptine and amitriptyline. Controlled double-blind trial in depressed alcoholic patients. Neuropsychobiology 19 (1988) 79-85
74. Malcolm, R., R. F. Anton, C. L. Randall, A. Johnston, K. Brady, A. Thevros: A placebo controlled trial of buspirone in anxious inpatient alcoholics. Alcohol. Clin. Exp. Res. 16 (1992) 1007-1013
75. Malec, E., T. Malec, M. A. Gagne, M. Dongier. Buspirone in the treatment of alcohol dependence. A placebo-controlled trial. Alcohol. Clin. Exp. Res. 20 (1996) 307-312
76. Malka, R., H. Loo, H. Ganry, A. Souche, C. Mary, A. Kamoun: Longterm administration of tianeptine in depressed patients after alcohol withdrawal. Br. J. Psychiatry, Suppl. 15 (1992) 66-71
77. Mason, B. J.: Dosing issues in the pharmacotherapy of alcoholism. Alcohol. Clin. Exp. Res. 20 Suppl. (1996): 10 A-16 A
78. Mason, B. J., J. H. Kocsis, E. C. Ritvo, R. B. Cutler: A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression. JAMA 275 (1996) 761-767
79. Mattila, M. J., K. Aranko, T. Seppala: Acute effects of buspirone and alcohol on psychomotor skills. J. Clin. Psychiatry 43 (1982) 56-60
80. Matussek, N.: Katecholamin-Hypothese. In: Beckmann, H., M. Osterheider (Hrsg.) Neurotransmitter und psychische Erkrankungen. Springer, Berlin, (1990), S.21-28
81. McLean, P. C., R. J. Ancill, T. K. Szulecka: Mianserin in the treatment of depressive symptoms in alcoholics. A double-blind placebo controlled study using a computer delivered self-rating scale. Psychiatria Polska 20 (1986) 417-427
82. McGrath, P. J., E. V. Nunes, J. W. Stewart, D. Goldman, V. Agosti, K. Ocepek-Welikson, F. M. Quitkin: Imipramine treatment of alcoholics with primary depression. Arch. Gen. Psychiatry 53 (1996) 232-240
83. McLellan, A. T., L. Luborsky, G. E. Woody, C. P. O'Brien, K. A. Druley: Predicting response to alcohol and drug abuse treatments. Role of psychiatric severity. Arch. Gen. Psychiatry 40 (1983) 620-625
84. Merry, J., C. M. Reynolds, J. Bailey, A. Coppen: Prophylactic treatment of alcoholism by lithium corbonate. A controlled study. Lancet ii (1976) 481-482
85. Modell, J. G., F. B. Glaser, L. Cyr, J. M. Mountz: Obsessive and compulsive characteristics of craving for alcohol in alcohol abuse and dependence. Alcohol. Clin. Exp. Res. 16 (1992) 272-274
86. Moffett, L. A., R. A. Radenhausen: Assessing depression in substance abusers: Beck Depression Inventory and SCL-90 R. Addict. Behav. 15 (1990) 179-181
87. Montgomery, S. A., M. A. Asperg: New depression scale designed to be sensitive to change. Br. J. Psychiatry 134 (1979) 382-389
88. Morrison, J. R.: Bipolar affective disorder and alcoholism. Am. J. Psychiatry 131 (1974) 1130-1133
89. Müller, W. E.: Cholinerge und GABAerge Mechanismen. In: Beckmann, H., M. Osterheider (Hrsg.) Neurotransmitter und psychische Erkrankungen. Springer, Berlin, ( 1990), S. 45-56
90. Mueller, T. I., R. L. Stout, S. Rudden, R. A. Brown, A. Gordon, D. A. Solomon, P. R. Recupero: A double-blind, placebo-controlled pilot study of carbamazepine for the treatment of alcohol dependence. Alcohol. Clin. Exp. Res. 21 (1997) 86-92
91. Murphy, G. E., R. D. Wetzel: The lifetime risk of suicide in alcoholism. Arch. Gen. Psychiatry 47 (1990) 383-392
92. Nakamura, M. M., J. E. Overall, L. E. Hollister, E. Radcliffe: Factors affecting outcome of depressive symptoms in alcoholics. Alcohol. Clin. Exp. Res. 7 (1983) 188-193
93. Nathan, P. E., N. A. Titler, L. M. Löwenstein, P. Solomon, A. M. Rossi: Behavioral analysis of chronic alcoholism: interaction of alcohol and human contact. Arch. Gen. Psychiatry 22 (1970) 419-430
94. Naranjo, C. A., E. M. Sellers, J. T. Sullivan, D. Woodley, K. Kadlec, K. Sykora: The serotonine inhibitor attentuate ethanol intake in problem drinkers. Clin. Pharmacol. Ther. 41 (1987) 266-274
95. Naranjo, C. A., K. Kadlec, P. Sanhuezza, D. Woodley-Remus, E. M. Sellers: Fluoxetine differentially alters alcohol intake and other consumatory behaviors in problem drinkers. Clin. Pharmacol. Ther. 48 (1990) 490-498
96. Naranjo, C. A., C. X. Poulos, K. E. Bremner, K. L. Lanctot: Fluoxetine attenuates alcohol intake and desire to drink. Int. Clin. Psychopharmacol. 9 (1994) 163-172
97. Naranjo, C. A., K. E. Bremner, K. L. Lanctot: Effects of citalopram and a brief psychosocial intervention on alcohol intake, dependence and problems. Addiction 90 (1995) 87-99
98. Nunes, E. V., P. J. McGrath, F. M. Quitkin, J. P. Stewart, W. Harrison, E. Tricamo, K. Ocepek-Welikson: Imipramine treatment of alcoholism with comorbid depression. Am. J. Psychiatry 150 (1993) 963-965
99. Powell, B. J., E. C. Penick, B. I. Liskow, A. S. Rice, W. McKnelly: Lithium compliance in alcoholics males: a six month follow-up study. Addict. Behav. 11 (1986) 135-140
100. Powell, B. J., E. C. Penick, B. I. Liskow, K. D. Riesenmy, S. L. Campion, E. F. Brown: Outcomes of co-morbid alcoholic men: A 1-year follow-up. Alcohol. Clin. Exp. Res. 16 (1992) 131-138
101. Powell, B. J., J. L. Campbell, J. F. Landon, B. I. Liskow, H. M. Thomas, E. J. Nickel, T. M. Dale, E. C. Penick, S. D. Samuelson, R. B. Lacoursiere: A double-blind, placebo-controlled study of nortriptyline and bromocriptine in male alcoholics subtyped by comorbid psychiatric disorders. Alcohol. Clin. Exp. Res. 19 (1995) 462-468
102. Preskorn, S. H., C. W. Hughes: Ethanol effects on brain concentrations of amitriptyline and the relationship to psychomotor function. Psychopharmacology 80 (1983) 217-220
103. Rajtar, G., Z. Kleinrok: Influence of some psychotropic drugs on the ethanol elimination by the isolated liver of rats chronically fed with ethanol. Acta Physiologica Polonica 41 (1990) 1-7
104. Regier, D. A., M. E. Farmer, D. S. Rae, B. Z. Locke, S. J. Keith, L. L. Judd, F. K. Goodwin: Comorbidity of mental disorders with alcohol and other drug abuse. JAMA 264 (1990) 2511-2518
105. Robins, L. N., D. A. Regier: Psychiatric disorders in America. Free Press, New York, 1990
106. Rommelspacher, H., L. G. Schmidt, H. Helmchen: Pathobiochemie und Pharmakotherapie des Alkoholentzugssyndroms. Nervenarzt 62 (1991) 649-657
107. Rounsaville, B. J., Z. S. Dolinsky, T. F. Babor, R. E. Meyer: Psychopathology as a predictor of treatment outcome in alcoholics. Arch. Gen. Psychiatry 44 (1987) 505-513
108. Ross, H. E., F. B. Glaser, T. Germanson: The prevalence of psychiatric disorders in patients with alcohol and other drug problems. Arch. Gen. Psychiatry 45 (1988) 1023-1031
109. Roy, A., M. Linnoila: CSF studies on alcoholism and related behaviours. Prog. Neuropsychopharmacol. Biol. Psychiatry 13 (1989) 505-511
110. Roy, A., J. Dejong, D. Lamparski, T. George, M. Linnoila: Depression among alcoholics. Arch. Gen. Psychiatry 48 (1991) 428-432
111. Roy, A.: Aetiology of secondary depression in male alcoholics. Br. J. Psychiatry 169 (1996) 753-757
112. Royer, R. J., M. J. Royer-Morrot, F. Paille, D. Barrucand, J. Schmitt, R. Defrance, C. Salvadori: Tianeptine and its main metabolite pharmacokinetics in chronic alcoholism and cirrhosis. Clin. Pharmacokinetics 16 (1989) 186-191
113. Sandoz, M., S. Vandel, B. Vandel, B. Bonin, G. Allers, R. Volmat: Biotransformation of amitriptyline in alcoholic depressive patients. Eur. J. Clin. Pharmacology 24 (1983) 615-621
114. Saß, H., H.-U. Wittchen, M. Zaudig (Hrsg.): Diagnostisches und statistisches Manual psychischer Störungen DSM-IV. Hogrefe, (Göttingen) 1996
115. Scholz, H.: Die Rehabilitation bei chronischem Alkoholismus. Enke, Stuttgart, 1986
116. Schuckit, M. A.: Genetic and clinical implications of alcoholism and affective disorders. Am. J. Psychiatry 143 (1986) 140-147
117. Schuckit, M. A., V. Hesselbrock: Alcohol dependency and anxiety disorders: what is the relationship? Am. J. Psychiatry 151 (1994) 1723-1734
118. Schuckit, M. A., M. Irwin, T. L. Smith: One-year incidence rate of major depression and other psychiatric disorders in 239 alcoholic men. Addiction 89 (1994) 441-445
119. Schutte, K. K., J. Hearst, R. H. Moos: Gender differences in the relations between depressive symptoms and drinking behavior among problem drinkers: a three-wave study. J. Consult. Clin. Psychol. 65 (1997) 392-404
120. Scott, D. B., D. Fagan, B. Tiplady: Effects of amitriptyline and zimelidine in combination with ethanol. Psychopharmacology 76 (1982) 209-211
121. Sellman, J. D., P. R. Joyce: Does depression predict relapse in the 6 months following treatment for men with alcohol dependence? Aust. N. Z. J. Psychiatry 30 (1996) 573-578
122. Seppala, T., M. Linnoila, E. Elonen, M. J. Mattila, M. Maki: Effect of tricyclic antidepressants and alcohol in psychomotor skills related to driving. Clin. Pharmacol. Ther. 17 (1975) 515-522
123. Seppala, T.: Psychomotor skills during acute and two-week treatment with mianserin (ORG GB 94) and amitriptyline, and their combined effects with alcohol. Ann. Clin. Res. 9 (1977) 66-72
124. Soyka, M.: Sucht und Schizophrenie. 1. Alkoholismus und Schizophrenie. Foitschr. Neurol. Psychiat. 62 (1994) 71-87
125. Soyka, M., M. Hollweg, D. Naber: Alkoholabhängigkeit und Depression. Klassifikation, Komorbidität, genetische und neurobiologische Aspekte. Nervenarzt 67 (1996) 896-904
126. Stahlberg, D., G. Osnabrügge, D. Frey: Die Theorie des Selbstwertschutzes und der Selbstwerterhöhung. In: Frey, D., M. Irle (Hrsg.) Theorien der Sozialpsychologie. Band 3. Huber, Bern, (1985) S.79-124
127. Stromberg, C., A. Suokas, T. Seppala, M. Kupari: Echocardiographic and psychometric effects of amitriptyline or imipramine plus alcohol. Eur. J. Clin. Pharmacol. 40 (1991) 349-354
128. Tamerin, J. S., J. H. Mendelson: The psychodynamics of chronic inebration: observations of alcoholics during the process of drinking in an experimental group setting. Am. J. Psychiatry 125 (1969) 58-71
129. Tartara, A., L. Formigli, F. Crema, M. Maurelli, E. Perucca, E. Marchioni, L. Manzo, L. Savoldi: Alcohol interactions with typical and atypical antidepressants. Neurobehav. Toxicol. Teratol. 7 (1985) 139-141
130. Ticku, M. K., T. Bruch: Alterations in gamma aminobutyric acid receptor sensitivity following acute and chronic ethanol treatments. J. Neurochem. 34 (1980) 417-423
131. Tiihonen, J., O. P. Ryynanen, J. Kauhanen, H. P. Hakola, M. Salaspuro: Citalopram in the treatment of alcoholism: a doubleblind placebo-controlled study. Pharmacopsychiatry 29 (1996) 27-29
132. Tollefson, G. D., J. Montague-Clouse, S. L. Tollefson: Treatment of comorbid generalized anxiety in a recently detoxified alcoholic population with selective serotonergic drug (buspirone). J. Clin. Psychopharmacol. 12 (1992) 19-26
133. Veltrup, C., T. Wetterling: Die psychometrische Erfassung des Craving bei entzugsbehandelten Alkoholabhängigen. In: Mann, K., G. Buchkremer (Hrsg.) Sucht. Grundlagen - Diagnostik - Therapie. Fischer Verlag, Stuttgart (1996) S. 195-202
134. Veltrup, C., T. Wetterling: Umgang mit Rückfallen. In: Wetterling, T., C. Veltrup: Diagnostik und Therapie von Alkoholproblemen. Springer, Berlin (1997) S. 135-145
135. Volk, S.: Medikamentöse Behandlung von Zwangsstörungen-eine vergleichende Betrachtung der Wirksamkeit von Clomipramin und Fluoxetin. Fortschr. Neurol. Psychiat. 63 (1995) Suppl. 1:28-32
136. von Bardeleben, U., I. Heuser, F. Holsboer: Human CRH stimulation response during acute withdrawal and after medium-term abstention from alcohol abuse. Psychoneuroendocrinology 14 (1989) 441-449
137. Weiss, R. D., S. M. Mirin: Tricyclic antidepressants in the treatment of alcoholism and drug abuse. J. Clin. Psychiatry 50 Suppl. (1989) 4-9
138. Weiss, R. D., S. M. Mirin, M. L. Griffin: Methodological considerations in the diagnosis of coexistence psychiatric disorders in substance abusers. Br. J. Addict. 87 (1992) 179-187
139. West, A. P., E. F. Gocka: Self-ratings of typical mood and behavior during recovery from alcohol abuse. A multivariate study of alcoholic men. Psychopathology 19 (1986) 303-308
140. Wetterling, T.: Delir-Stand der Forschung. Fortschr. Neurol. Psychiat. 62 (1994) 280-289
141. Wetterling, T., C. Veltrup, K. Junghanns: Craving-ein fundiertes Konzept? Fortschr. Neurol. Psychiat. 64 (1996) 142-152
142. Wetterling, T., C. Veltrup, K. Junghanns: Mögliche Indikationen zur Behandlung mit "Anti-Craving"-Medikamenten. Sucht 42 (1996) 323-330
143. Wienberg, G.: Struktur und Dynamik der Suchtkrankenversorgung in der Bundesrepublik-ein Versuch, die Realität vollständig wahrzunehmen. In: Wienberg, G. (Hrsg.) Die vergessene Mehrheit. Psychiatrie-Verlag, Bonn, 1992; S. 12-57
144. Wilde, M. I., P. Benfield: Tianeptine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depression and coexisting anxiety and depression. Drugs 49 (1995) 411-439
145. Winokur, G., W. Coreyll, H. S. Akiskal, J. D. Maser, M. B. Keller, J. Endicott, T. Mueller: Alcoholism in manic-depressive (bipolar) illness. Familial illness, course of illness, and the primary-secondary distinction. Am. J. Psychiatry 152 (1995) 365-372
146. Wren, J. C., N. S. Kline, T. B. Cooper, E. Varga, O. Canal: Evaluation of lithium therapy in alcoholism. Clin. Med. 1 (1974) 33-36
147. Ziegler, B., S. Grub-Seyer, G. Huber: Schlafstörungen bei Alkoholabhängigen. Polysomnographische und computertomographische Untersuchungen. Nervenheilkunde 11 (1992) 298-305
148. Zung, W. W. K.: A self-rating depression scale. Arch. Gen. Psychiatry 12 (1965) 63-70